Kairos Pharma Ltd. (KAPA)
AMEX: KAPA
· Real-Time Price · USD
1.19
-0.05 (-4.03%)
At close: Aug 15, 2025, 3:59 PM
1.22
2.68%
After-hours: Aug 15, 2025, 07:56 PM EDT
Kairos Pharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Cash & Equivalents | 3.03M | 3.62M | 1.27M | 3.22M | 21K | 40K | 93K | 99K | 232K | 357K | 437K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.69M | 1.71M | 1.38M | n/a | 690K | 571K | 482K | 410K | 258K | 129K | 57K |
Receivables | n/a | n/a | n/a | 1.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.8M | 55K | 2.9M | -1.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 4.84M | 6.05M | 4.17M | 4.74M | 38K | 59K | 101K | 116K | 258K | 374K | 437K |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | 142K | 182K | 222K | 262K | 302K | 342K | 382K | 422K | 462K | 502K | 542K |
Total Long-Term Assets | 1.83M | 1.89M | 1.6M | 262K | 992K | 913K | 864K | 832K | 720K | 631K | 599K |
Total Assets | 6.67M | 7.94M | 5.77M | 5M | 1.03M | 972K | 965K | 948K | 978K | 1M | 1.04M |
Account Payables | 676K | 805K | 992K | 1.53M | 1.92M | 1.89M | 2.4M | 1.41M | 1.93M | 1.73M | 1.63M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | 142K | 102K | 4K | 4K | 4K | 4K | 4K | 4K |
Other Current Liabilities | n/a | n/a | n/a | n/a | -102K | 821K | n/a | -4K | n/a | n/a | n/a |
Total Current Liabilities | 676K | 805K | 992K | 1.67M | 1.92M | 2.72M | 2.4M | 1.41M | 1.94M | 1.74M | 1.63M |
Long-Term Debt | n/a | n/a | n/a | n/a | 677K | 657K | 638K | 612K | 602K | 592K | 582K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | 677K | 657K | 638K | 612K | 602K | 592K | 582K |
Total Liabilities | 676K | 805K | 992K | 1.67M | 1.92M | 3.37M | 3.04M | 1.41M | 2.54M | 2.33M | 2.21M |
Total Debt | n/a | n/a | n/a | 142K | 779K | 661K | 638K | 616K | 606K | 596K | 586K |
Common Stock | 18K | 500K | 14K | 13K | 11K | 11K | 11K | 11K | 103K | 103K | 10K |
Retained Earnings | -11.5M | -10.08M | -8.81M | -7.83M | -6.79M | -6.62M | -6.21M | -5.09M | -4.78M | -4.55M | -4.4M |
Comprehensive Income | n/a | 484K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a |
Shareholders Equity | 6M | 7.13M | 4.78M | 3.33M | -885K | -919K | -2.08M | -463K | -1.56M | -1.32M | -1.18M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |